8._AP_Price_List_Attachment_7.xlsx
XLSX spreadsheet 26 KB Posted
- Attached to
- Lab Testing Services Federal contract opportunity
- Solicitation number
- FA8601-17-R-0060
About this file
Attachment 7
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| 8._Updated_Price_List_Attachment_7.xlsx | XLSX spreadsheet | |
| 2._Provisions_&_Clauses_Redacted.pdf | ||
| 7._FAR_52.212-3_Attachment_6.pdf | ||
| 5._FAR_52.222-25_Attachment_4.pdf | ||
| 4._FAR_52.222-22_Attachment_3.pdf | ||
| 3._Performance_Work_Statement.pdf | ||
| 6._FAR_52.209-2_Attachment_5.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1 Please provide a price for all tests. If there is a test you cannot or do not perform, please mark "N/A" in the Unit Price column.
| CPT | DESCRIPTION | Quantity | Unit of Issue (ea.) | Price per Service Count | Total |
| 81206 | BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; major breakpoint, qualitative or quantitative | $ - 0 | |||
| 81207 | minor breakpoint, qualitative or quantitative | $ - 0 | |||
| 81210 | BRAF (v-raf murine sarcoma viral oncogene homolog B1) (eg, colon cancer), gene analysis, V600E variant | $ - 0 | |||
| 81211 | BRCA1&2 SEQ & COM DUP/DEL | $ - 0 | |||
| 81212 | BRCA1&2 185&5385&6174 VAR | $ - 0 | |||
| 81213 | BRCA1&2 UNCOM DUP/DEL VAR | $ - 0 | |||
| 81214 | BRCA1 FULL SEQ & COM DUP/DEL | $ - 0 | |||
| 81215 | BRCA1 GENE KNOWN FAM VARIANT | $ - 0 | |||
| 81217 | BRCA2 GENE KNOWN FAM VARIANT | $ - 0 | |||
| 81225 | Cyp2c19 gene com variants | $ - 0 | |||
| 81235 | EGFR (epidermal growth factor receptor) (eg, non-small cell lung cancer) gene analysis, common variants (eg, exon 19 LREA deletion, L858R, T790M, G719A, G719S, L861Q) | $ - 0 | |||
| 81245 | FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis, internal tandem duplication (ITD) variants (ie, exons 14, 15) | $ - 0 | |||
| 81261 | IGH@ (Immunoglobulin heavy chain locus) (eg, leukemias and lymphomas, B-cell), gene rearrangement analysis to detect abnormal clonal population(s); amplified methodology (eg, polymerase chain reaction) | $ - 0 | |||
| 81263 | IGH@ (Immunoglobulin heavy chain locus) (eg, leukemia and lymphoma, B-cell), variable region somatic mutation analysis | $ - 0 | |||
| 81264 | IGK REARRANGEABN CLONAL POP | $ - 0 | |||
| 81267 | Chimerism (engraftment) analysis, post transplantation specimen (eg, hematopoietic stem cell), includes comparison to previously performed baseline analyses; without cell selection | $ - 0 | |||
| 81270 | JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe (V617F) variant | $ - 0 | |||
| 81275 | KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene) (eg, carcinoma) gene analysis, variants in codons 12 and 13 | $ - 0 | |||
| 81290 | MCOLN1 GENE | $ - 0 | |||
| 81291 | MTHFR GENE | $ - 0 | |||
| 81292 | MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis | $ - 0 | |||
| 81293 | known familial variants | $ - 0 | |||
| 81294 | MLH1 GENE DUP/DELETE VARIANT | $ - 0 | |||
| 81295 | MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis | $ - 0 | |||
| 81296 | known familial variants | $ - 0 | |||
| 81297 | MSH2 GENE DUP/DELETE VARIANT | $ - 0 | |||
| 81298 | MSH6 (mutS homolog 6 [E. coli]) (eg, hereditary nonpolyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis | $ - 0 | |||
| 81299 | MSH6 GENE KNOWN VARIANTS | $ - 0 | |||
| 81300 | MSH6 GENE DUP/DELETE VARIANT | $ - 0 | |||
| 81301 | Microsatellite instability analysis (eg, hereditary nonpolyposis colorectal cancer, Lynch syndrome) of markers for mismatch repair deficiency (eg, BAT25, BAT26), includes comparison of neoplastic and normal tissue, if performed | $ - 0 | |||
| 81302 | MECP2 GENE FULL SEQ | $ - 0 | |||
| 81303 | MECP2 GENE KNOWN VARIANT | $ - 0 | |||
| 81304 | MECP2 GENE DUP/DELET VARIANT | $ - 0 | |||
| 81310 | NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, exon 12 variants | $ - 0 | |||
| 81315 | PML/RARalpha, (t(15;17)), (promyelocytic leukemia/ retinoic acid receptor alpha) (eg, promyelocytic leukemia) translocation analysis; common breakpoints (eg, intron 3 and intron 6), qualitative or quantitative | $ - 0 | |||
| 81316 | PML/RARALPHA 1 BREAKPOINT | $ - 0 | |||
| 81317 | PMS2 GENE FULL SEQ ANALYSIS | $ - 0 | |||
| 81318 | PMS2 KNOWN FAMILIAL VARIANTS | $ - 0 | |||
| 81319 | PMS2 GENE DUP/DELET VARIANTS | $ - 0 | |||
| 81321 | PTEN GENE FULL SEQUENCE | $ - 0 | |||
| 81340 | TRB@ GENE REARRANGE AMPLIFY | $ - 0 | |||
| 81342 | TRG GENE REARRANGEMENT ANAL | $ - 0 | |||
| 81350 | UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) (eg, irinotecan metabolism), gene analysis, common variants (eg, *28, *36, *37) | $ - 0 | |||
| 81400 | MOPATH PROCEDURE LEVEL 1 | $ - 0 | |||
| 81401 | Molecular pathology procedure, Level 2 (eg, 2-10 SNPs, 1 methylated variant, or 1 somatic variant [typically using nonsequencing target variant analysis], or detection of a dynamic mutation disorder/triplet repeat) | $ - 0 | |||
| 81402 | Molecular pathology procedure, Level 3 (eg, >10 SNPs, 2-10 methylated variants, or 2-10 somatic variants [typically using non-sequencing target variant analysis], immunoglobulin and T-cell receptor gene rearrangements, duplication/deletion variants of 1 exon, loss of heterozygosity [LOH], uniparental disomy [UPD]) | $ - 0 | |||
| 81403 | Molecular pathology procedure, Level 4 (eg, analysis of single exon by DNA sequence analysis, analysis of >10 amplicons using multiplex PCR in 2 or more independent reactions, mutation scanning or duplication/deletion variants of 2-5 exons) | $ - 0 | |||
| 81404 | Molecular pathology procedure, Level 5 (eg, analysis of 2-5 exons by DNA sequence analysis, mutation scanning or duplication/deletion variants of 6-10 exons, or characterization of a dynamic mutation disorder/triplet repeat by Southern blot analysis) | $ - 0 | |||
| 81405 | Molecular pathology procedure, Level 6 (eg, analysis of 6-10 exons by DNA sequence analysis, mutation scanning or duplication/deletion variants of 11-25 exons, regionally targeted cytogenomic array analysis) | $ - 0 | |||
| 81406 | MOPATH PROCEDURE LEVEL 7 | $ - 0 | |||
| 81407 | MOPATH PROCEDURE LEVEL 8 | $ - 0 | |||
| 81408 | MOPATH PROCEDURE LEVEL 9 | $ - 0 | |||
| 81445 | Oncovantage | $ - 0 | |||
| 81479 | UNLISTED MOLECULAR PATHOLOGY PROCEDURE | $ - 0 | |||
| 86152 | Cell enumeration using immunologic selection and ident in fluid spec (circulating tumor cells) | $ - 0 | |||
| 86153 | Cell enumer using immun sel and ident in fluid spec; physician interp & report, when required | $ - 0 |
| CPT | DESCRIPTION | Quantity | Unit of Issue (ea.) | Price per Service Count | Total |
| 82013 | ACETYLCHOLINESTERASE | $ - 0 | |||
| 82106 | ALPHA-FETOPROTEIN; AMNIOTIC FLUID | $ - 0 | |||
| 82232 | BETA-2 MICROGLOBULIN | $ - 0 | |||
| 82657 | ENZYM ACTIV-CELLS/TISS NES; NONRAD | $ - 0 | |||
| 83033 | HGB; F QUAL TEST FECAL | $ - 0 | |||
| 84702 | GONADOTROPIN CHORIONIC; QUAN | $ - 0 | |||
| 84999 | UNLISTED CHEMISTRY PROCEDURE | $ - 0 | |||
| 85060 | BLD SMEAR PERIPHRL INTRPT W/REPORT | $ - 0 | |||
| 85097 | BONE MARROW; SMEAR INTERPT ONLY | $ - 0 | |||
| 85540 | LEUKOCYTE ALKALINE PHOSPHATASE W/C | $ - 0 | |||
| 86336 | INHIBIN A | $ - 0 | |||
| 86356 | MONONUCLEAR CELL ANTIGEN,QUANTITATIVE,EACH ANTIGEN | $ - 0 | |||
| 87480 | AGT-DNA/RNA; CANDIDA SPECIES-DIREC | $ - 0 | |||
| 87481 | AGT-DNA/RNA; CANDIDA SPECIES-AMPLI | $ - 0 | |||
| 87491 | AGT-DNA/RNA; CHLAMYDIA TRACH-AMPLI | $ - 0 | |||
| 87510 | AGT-DNA/RNA; GARDNERELLA VAG-DIREC | $ - 0 | |||
| 87511 | AGT-DNA/RNA; GARDNERELLA VAG-AMPLI | $ - 0 | |||
| 87529 | AGT-DNA/RNA; HERPES SIMPLEX-AMPLI | $ - 0 | |||
| 87591 | AGT-DNA/RNA; NEISSER GONORRHEA-AMP | $ - 0 | |||
| 87623 | HPV LOW RISK | $ - 0 | |||
| 87624 | HPV HIGH RISK | $ - 0 | |||
| 87625 | HPV 16/18 GENOTYPE | $ - 0 | |||
| 87653 | INFECTIOUS AGENT DETECTION BY NUCLEIC ACID(DNA OR RNA); STREP, GROUP B, AMPLIFI | $ - 0 | |||
| 87660 | INFECT AGENT DETECT BY NUCLEIC ACID TRICHOMONAS VAGINALIS DIRECT PROBE TECH. | $ - 0 | |||
| 87661 | TRICHOMONAS VAGINALIS AMPLIF | $ - 0 | |||
| 87798 | AGT-DNA/RNA; NOS-AMPLIFIED PROBE | $ - 0 | |||
| 88104 | CYTOPATH NO CERV/VAG; SMEARS W/INT | $ - 0 | |||
| 88104-TC | CYTOPATH NO CERV/VAG; SMEARS W/INT - TC Only | $ - 0 | |||
| 88106 | CYTOPATH FL NONGYN, FILTER | $ - 0 | |||
| 88106-TC | CYTOPATH FL NONGYN, FILTER - TC Only | $ - 0 | |||
| 88107 | CYTOPATH NO CERV/VAG; PREP W/INTRP | $ - 0 | |||
| 88108 | CYTOPATH CONCENTRA-SMEARS & INTERP | $ - 0 | |||
| 88108-TC | CYTOPATH CONCENTRA-SMEARS & INTERP - TC Only | $ - 0 | |||
| 88112 | CYTOPATH, SELECTIVE CELL. ENH. TECH W/ INTRPRTTN EXPT CERV OF VAG CERV OR VAG. | $ - 0 | |||
| 88112-TC | CYTOPATH, SELECTIVE CELL. ENH. TECH W/ INTRPRTTN EXPT CERV OF VAG CERV OR VAG. - TC Only | $ - 0 | |||
| 88120 | CYTOPATHOLOGY, IN SITU HYBRIDIZATION (EG, FISH), URINARY TRACT SPECIMEN WITH MORPHOMETRIC ANALYSIS, 3-5 MOLECULAR PROBES, EACH SPECIMEN; MANUAL | $ - 0 | |||
| 88120 26 | CYTOPATHOLOGY, IN SITU HYBRIDIZATION (EG, FISH), URINARY TRACT SPECIMEN WITH MORPHOMETRIC ANALYSIS, 3-5 MOLECULAR PROBES, EACH SPECIMEN; MANUAL - PC | $ - 0 | |||
| 88120 TC | CYTOPATHOLOGY, IN SITU HYBRIDIZATION (EG, FISH), URINARY TRACT SPECIMEN WITH MORPHOMETRIC ANALYSIS, 3-5 MOLECULAR PROBES, EACH SPECIMEN; MANUAL - TC | $ - 0 | |||
| 88121 | CYTOPATHOLOGY, IN SITU HYBRIDIZATION (EG, FISH), URINARY TRACT SPECIMEN WITH MORPHOMETRIC ANALYSIS, 3-5 MOLECULAR PROBES, EACH SPECIMEN; USING COMPUTER-ASSISTED TECHNOLOGY | $ - 0 | |||
| 88121 26 | CYTOPATHOLOGY, IN SITU HYBRIDIZATION (EG, FISH), URINARY TRACT SPECIMEN WITH MORPHOMETRIC ANALYSIS, 3-5 MOLECULAR PROBES, EACH SPECIMEN; MANUAL - PC | $ - 0 | |||
| 88121 TC | CYTOPATHOLOGY, IN SITU HYBRIDIZATION (EG, FISH), URINARY TRACT SPECIMEN WITH MORPHOMETRIC ANALYSIS, 3-5 MOLECULAR PROBES, EACH SPECIMEN; MANUAL - TC | $ - 0 | |||
| 88125 | CYTOPATHOLOGY, FORENSIC | $ - 0 | |||
| 88125 26 | CYTOPATHOLOGY, FORENSIC - PC | $ - 0 | |||
| 88125 TC | CYTOPATHOLOGY, FORENSIC - TC | $ - 0 | |||
| 88141 | CYTOPATH CERV/VAG; REQ INTERPT PHY | $ - 0 | |||
| 88142 | CYTPTH CERV/VAG; MANUAL SCRN-SUPRV | $ - 0 | |||
| 88160 | CYTPATH SMEARS; SCREEN & INTRPT | $ - 0 | |||
| 88160-TC | CYTPATH SMEARS; SCREEN & INTRPT - TC Only | $ - 0 | |||
| 88161 | CYTOPATH SMEAR; PREP/SCREEN/INTERP | $ - 0 | |||
| 88161-TC | CYTOPATH SMEAR; PREP/SCREEN/INTERP - TC Only | $ - 0 | |||
| 88162-TC | CYTOPATH SMEAR: PREP/SCREEN/INTREP EXT STUDY - TC Only | $ - 0 | |||
| 88164 | CYTOPATH SLIDES-CERV/VAG; MAN SCRN | $ - 0 | |||
| 88172 | CYTOPATHOLOGY,EVAL FINE NEEDLE ASP;IMM CYTO STUDY TO DET ADE FOR DX,FIRST EVAL | $ - 0 | |||
| 88172-TC | CYTOPATHOLOGY,EVAL FINE NEEDLE ASP;IMM CYTO STUDY TO DET ADE FOR DX,FIRST EVAL - TC Only | $ - 0 | |||
| 88173 | EVAL FINE NEEDL ASPIRAT;INTRPT/REP | $ - 0 | |||
| 88173-TC | EVAL FINE NEEDL ASPIRAT;INTRPT/REP - TC Only | $ - 0 | |||
| 88174 | CYTOPATH, CERV/VAG COLLECTED IN PRES FLUID, AUTOMATED THIN LAYER PREP | $ - 0 | |||
| 88175 | W/ SCREENING BY AUTOMATED SYSTEM & MAN. RESCREENING, UNDER PHYS. SPRVSN | $ - 0 | |||
| 88177 | CYTOPATHOLOGY, EVAL FINE NEEDLE ASPIRATE; INTERPRETATION & REPORT | $ - 0 | |||
| 88177 26 | CYTOPATHOLOGY, EVAL FINE NEEDLE ASPIRATE; INTERPRETATION & REPORT - PC | $ - 0 | |||
| 88177 TC | CYTOPATHOLOGY, EVAL FINE NEEDLE ASPIRATE; INTERPRETATION & REPORT - TC | $ - 0 | |||
| 88182 | FLO CYTOMETRY; CELL CYCLE/DNA ANAL | $ - 0 | |||
| 88182-26 | FLO CYTOMETRY; CELL CYCLE/DNA ANAL - PC Only | $ - 0 | |||
| 88182-TC | FLO CYTOMETRY; CELL CYCLE/DNA ANAL - TC Only | $ - 0 | |||
| 88184 | FLOW CYMETRY, CELL SURF., CYTOPLASMIC, OR NUC. MARKER, TC ONLY, 1ST MARKER | $ - 0 | |||
| 88185 | EACH ADDITIONAL MARKER (LIST SEPERATELY IN ADDITION TO CODE FOR FIRST MARKER) | $ - 0 | |||
| 88187 | FLOW CYMETRY, INTERPRETATION, 2 TO 8 | $ - 0 | |||
| 88188 | 9 TO 15 MARKERS | $ - 0 | |||
| 88189 | 16 OR MORE MARKERS | $ - 0 | |||
| 88230 | TISS CULT NON-NEOPLASM; LYMPHOCYTE | $ - 0 | |||
| 88233 | TISS CULT NON-NEOPLASM; SKIN | $ - 0 | |||
| 88235 | TISS CULT NON-NEOPLAS; AMNIOT FLUI | $ - 0 | |||
| 88237 | TISS CULT NEOPLASM; MARROW/BLD CEL | $ - 0 | |||
| 88239 | TISS CULTURE NEOPLASM; SOLID TUMOR | $ - 0 | |||
| 88249 | CHROMOSOME ANALYSIS 100 | $ - 0 | |||
| 88261 | CHROMO ANALY; CT 5 CEL 1 KAROTYPE | $ - 0 | |||
| 88262 | CHROMO ANALY; CT 15-20 CELL 2 KARY | $ - 0 | |||
| 88263 | CHROMO ANALY; CT 45 CEL MOSAICISM | $ - 0 | |||
| 88264 | CHROMOSOME ANALY; ANALY 20-25 CELL | $ - 0 | |||
| 88267 | CHROMO ANALY AMNIO FLUID CT 15 CEL | $ - 0 | |||
| 88269 | CHROMO ANAL AMNIO FLD CT 6-12 COLN | $ - 0 | |||
| 88271 | MOLEC CYTOGEN; DNA PROBE EA | $ - 0 | |||
| 88272 | MOLEC CYTOGEN; CHROMOSOM HYBRID 3- | $ - 0 | |||
| 88273 | CYTOGEN; CHROMOSOM HYBRID 10-3O CE | $ - 0 | |||
| 88274 | CYTOGEN; INTERPHASE HYBRID 25-99 | $ - 0 | |||
| 88275 | CYTOGEN; INTERPHASE HYBRID 100-300 | $ - 0 | |||
| 88280 | CHROMOSOME ANALY; ADD KARYOTYPES E | $ - 0 | |||
| 88283 | CHROMO ANALY; ADD SPECIALIZED BAND | $ - 0 | |||
| 88285 | CHROMO ANALY; ADD CELLS COUNTED EA | $ - 0 | |||
| 88289 | CHROMO ANALY; ADD HIGH RESOLUTION | $ - 0 | |||
| 88300 | SURGICAL PATHOLOGY LEVEL I | $ - 0 | |||
| 88300-26 | SURGICAL PATHOLOGY LEVEL I - PC Only | $ - 0 | |||
| 88300-TC | SURGICAL PATHOLOGY LEVEL I - TC Only | $ - 0 | |||
| 88302 | SURGICAL PATHOLOGY LEVEL II | $ - 0 | |||
| 88302-26 | SURGICAL PATHOLOGY LEVEL II - PC Only | $ - 0 | |||
| 88302-TC | SURGICAL PATHOLOGY LEVEL II - TC Only | $ - 0 | |||
| 88304 | SURGICAL PATHOLOGY LEVEL III | $ - 0 | |||
| 88304-26 | SURGICAL PATHOLOGY LEVEL III - PC Only | $ - 0 | |||
| 88304-TC | SURGICAL PATHOLOGY LEVEL III - TC Only | $ - 0 | |||
| 88305 | SURGICAL PATHOLOGY LEVEL IV | $ - 0 | |||
| 88305-26 | SURGICAL PATHOLOGY LEVEL IV - PC Only | $ - 0 | |||
| 88305-TC | SURGICAL PATHOLOGY LEVEL IV - TC Only | $ - 0 | |||
| 88307 | SURGICAL PATHOLOGY LEVEL V | $ - 0 | |||
| 88307-26 | SURGICAL PATHOLOGY LEVEL V - PC Only | $ - 0 | |||
| 88307-TC | SURGICAL PATHOLOGY LEVEL V - TC Only | $ - 0 | |||
| 88309 | SURGICAL PATHOLOGY LEVEL VI | $ - 0 | |||
| 88309-26 | SURGICAL PATHOLOGY LEVEL VI - PC Only | $ - 0 | |||
| 88309-TC | SURGICAL PATHOLOGY LEVEL VI - TC Only | $ - 0 | |||
| 88311 | DECALCIFICATION PROC | $ - 0 | |||
| 88311-26 | DECALCIFICATION PROC - PC Only | $ - 0 | |||
| 88311-TC | DECALCIFICATION PROC - TC Only | $ - 0 | |||
| 88312 | SPECIAL STAINS; GRP I FOR MICROORGANISMS, INCLUDING INTERPRETATIONS & REPORT | $ - 0 | |||
| 88312-26 | SPECIAL STAINS; GRP I FOR MICROORGANISMS, INCLUDING INTERPRETATIONS & REPORT - PC Only | $ - 0 | |||
| 88312-TC | SPECIAL STAINS; GRP I FOR MICROORGANISMS, INCLUDING INTERPRETATIONS & REPORT - TC Only | $ - 0 | |||
| 88313 | SPEC STAINS; GROUP II, ALL OTH EX IMMUNOCYTO & IMMUNOPEROX STA, INC INT/REP | $ - 0 | |||
| 88313-26 | SPEC STAINS; GROUP II, ALL OTH EX IMMUNOCYTO & IMMUNOPEROX STA, INC INT/REP - PC Only | $ - 0 | |||
| 88313-TC | SPEC STAINS; GROUP II, ALL OTH EX IMMUNOCYTO & IMMUNOPEROX STA, INC INT/REP - TC Only | $ - 0 | |||
| 88314 | SPEC STAIN; HISTOCHEM STAIN W/FROZ SECT, INC INT/REP | $ - 0 | |||
| 88314-26 | SPEC STAIN; HISTOCHEM STAIN W/FROZ SECT, INC INT/REP - PC Only | $ - 0 | |||
| 88314-TC | SPEC STAIN; HISTOCHEM STAIN W/FROZ SECT, INC INT/REP - TC Only | $ - 0 | |||
| 88319 | DETERM HSTOCHEM/CYTCHEM ID ENZYM E | $ - 0 | |||
| 88319-TC | DETERM HSTOCHEM/CYTCHEM ID ENZYM E - TC Only | $ - 0 | |||
| 88321 | CONS & REPRT REF SLIDES PREP ELSEW | $ - 0 | |||
| 88323 | CONS & REPRT REF MAT REQ PREP SLID | $ - 0 | |||
| 88323-26 | CONS & REPRT REF MAT REQ PREP SLID - PC Only | $ - 0 | |||
| 88323-TC | CONS & REPRT REF MAT REQ PREP SLID - TC Only | $ - 0 | |||
| 88325 | CONS COMP W/REVW RECORD/SPECMN/REP | $ - 0 | |||
| 88331 | PATH CONS DURNG SURG; FROZEN 1 SPE | $ - 0 | |||
| 88331-26 | PATH CONS DURNG SURG; FROZEN 1 SPE - PC Only | $ - 0 | |||
| 88331-TC | PATH CONS DURNG SURG; FROZEN 1 SPE - TC Only | $ - 0 | |||
| 88332-TC | EACH ADD TIS BLOCK W/FROZ SEC(LIST SE IN ADD TO CODE FOR PRIM PROC);+88331 - TC Only | $ - 0 | |||
| 88333-TC | PATHOLOGY CONS DURING SURG, CYTOLOGIC EXAM INITIAL SITE - TC Only | $ - 0 | |||
| 88334-TC | CYTO EXAM EACH ADD SITE(LIST SEP IN ADD TO CODE FOR PRIM PROC);+88331 OR 88333 - TC Only | $ - 0 | |||
| 88341 | Immunohisto antibody slide | $ - 0 | |||
| 88341TC | Immunohisto antibody slide | $ - 0 | |||
| 8834126 | Immunohisto antibody slide | $ - 0 | |||
| 88342 | IMMUNOCYTOCHEMISTRY EA ANTIB - initial stain | $ - 0 | |||
| 88342-26 | IMMUNOCYTOCHEMISTRY EA ANTIB - initial stain - PC Only | $ - 0 | |||
| 88342-TC | IMMUNOCYTOCHEMISTRY EA ANTIB - initial stain - TC Only | $ - 0 | |||
| 88343 | IMMUNOCYTOCHEMISTRY EA ANTIB - each add'l stain | $ - 0 | |||
| 88343-26 | IMMUNOCYTOCHEMISTRY EA ANTIB - each add'l stain - PC Only | $ - 0 | |||
| 88343-TC | IMMUNOCYTOCHEMISTRY EA ANTIB - each add'l stain - TC Only | $ - 0 | |||
| 88344 | Immunohisto antibody slide | $ - 0 | |||
| 88344-26 | Immunohisto antibody slide | $ - 0 | |||
| 88344-TC | Immunohisto antibody slide | $ - 0 | |||
| 88346 | IMMUNOFLUOR STUDY EA ANTIB; DIRECT | $ - 0 | |||
| 88346-26 | IMMUNOFLUOR STUDY EA ANTIB; DIRECT - PC Only | $ - 0 | |||
| 88346-TC | IMMUNOFLUOR STUDY EA ANTIB; DIRECT - TC Only | $ - 0 | |||
| 88347 | IMMUNOFLUOR STUDY EA ANTIB; INDIRE | $ - 0 | |||
| 88347-26 | IMMUNOFLUOR STUDY EA ANTIB; INDIRE - PC Only | $ - 0 | |||
| 88347-TC | IMMUNOFLUOR STUDY EA ANTIB; INDIRE - TC Only | $ - 0 | |||
| 88348 | ELECTRON MICRO; DX | $ - 0 | |||
| 88348-26 | ELECTRON MICRO; DX - PC Only | $ - 0 | |||
| 88348-TC | ELECTRON MICRO; DX - TC Only | $ - 0 | |||
| 88349 | ELECTRON MICRO; SCANNING | $ - 0 | |||
| 88349-26 | ELECTRON MICRO; SCANNING - PC Only | $ - 0 | |||
| 88349-TC | ELECTRON MICRO; SCANNING - TC Only | $ - 0 | |||
| 88355 | MORPHOMETRIC ANALYSIS; SKELETAL MUSCLE | $ - 0 | |||
| 88355 26 | MORPHOMETRIC ANALYSIS; SKELETAL MUSCLE - PC | $ - 0 | |||
| 88355 TC | MORPHOMETRIC ANALYSIS; SKELETAL MUSCLE - TC | $ - 0 | |||
| 88356 | MORPHOMETRIC ANALYSIS; NERVE | $ - 0 | |||
| 88356 26 | ELECTRON MICROSCOPY; SCANNING - PC | $ - 0 | |||
| 88356 TC | ELECTRON MICROSCOPY; SCANNING - TC | $ - 0 | |||
| 88358 | MORPHOMETRIC ANALY; TUMOR | $ - 0 | |||
| 88358-26 | MORPHOMETRIC ANALY; TUMOR - PC Only | $ - 0 | |||
| 88358-TC | MORPHOMETRIC ANALY; TUMOR - TC Only | $ - 0 | |||
| 88360 | MORPH ANALYSIS, TUMOR IMMUNOHISTOCHEM QUANT OR SEMIQUANT, EA ANTIBODY; MANUAL | $ - 0 | |||
| 88360-26 | MORPH ANALYSIS, TUMOR IMMUNOHISTOCHEM QUANT OR SEMIQUANT, EA ANTIBODY; MANUAL - PC Only | $ - 0 | |||
| 88360-TC | MORPH ANALYSIS, TUMOR IMMUNOHISTOCHEM QUANT OR SEMIQUANT, EA ANTIBODY; MANUAL - TC Only | $ - 0 | |||
| 88361 | TUMOR IMMUNOHISTOCHEMISTRY QUANTITATIVE OR SEMIQUANTITATIVE | $ - 0 | |||
| 88361-26 | TUMOR IMMUNOHISTOCHEMISTRY QUANTITATIVE OR SEMIQUANTITATIVE - PC Only | $ - 0 | |||
| 88361-TC | TUMOR IMMUNOHISTOCHEMISTRY QUANTITATIVE OR SEMIQUANTITATIVE - TC Only | $ - 0 | |||
| 88362-TC | NERV TEASING PREP - TC Only | $ - 0 | |||
| 88365 | TISS IN SITU HYBRIDIZ INTRPT & REP | $ - 0 | |||
| 88365-26 | TISS IN SITU HYBRIDIZ INTRPT & REP - PC Only | $ - 0 | |||
| 88365-TC | TISS IN SITU HYBRIDIZ INTRPT & REP - TC Only | $ - 0 | |||
| 88367-TC | MORPHOMETRIC ANALYSIS, IN SITU HYBRIDIZATION, EA PROBE, USING COM ASSTD TECH. - TC Only | $ - 0 | |||
| 88368 | MORPH ANALYSIS, IN SITU HYBRID EA PROBE;MANUAL | $ - 0 | |||
| 88368-26 | MORPH ANALYSIS, IN SITU HYBRID EA PROBE;MANUAL - PC Only | $ - 0 | |||
| 88368-TC | MORPH ANALYSIS, IN SITU HYBRID EA PROBE;MANUAL - TC Only | $ - 0 | |||
| 88380-TC | MICRODISSECTION(IE,SAMPLE PREP OF MICROSCOPICALLY IDENT TARGET); LASER CAPTURE - TC Only | $ - 0 | |||
| 88381-TC | MICRODISSECTION; MANUAL - TC Only | $ - 0 | |||
| 88387 | TISSUE EXAM MOLECULAR STUDY | $ - 0 | |||
| 88387 26 | TISSUE EXAM MOLECULAR STUDY - PC | $ - 0 | |||
| 88387 TC | TISSUE EXAM MOLECULAR STUDY - TC | $ - 0 | |||
| 88388 | TISSUE EXAM MOLECULAR STUDY - ADD ON | $ - 0 | |||
| 88388 26 | TISSUE EXAM MOLECULAR STUDY - ADD ON - PC | $ - 0 | |||
| 88388 TC | TISSUE EXAM MOLECULAR STUDY - ADD ON - TC | $ - 0 | |||
| 88377 | M/phmtrc alys ishquant/semiq | $ - 0 |
| CPT | DESCRIPTION | Quantity | Unit of Issue (ea.) | Price per Service Count | Total |
| 0019537 | TSH WITH HAMA TREATMENT | $ - 0 | |||
| 0950669 | MIXING STUDIES | $ - 0 | |||
| 0950083 | PLATELET FUNC SCR | $ - 0 | |||
| 0005022 | REDUC SUB, FECES QL | $ - 0 | |||
| 0950084 | ADP | $ - 0 | |||
| 0907190 | THYROGLOBULIN AB | $ - 0 | |||
| 0907239 | LEU & LYM 21 MARKERS | $ - 0 | |||
| 0907234 | LEU & LYM 16 MARKERS | $ - 0 | |||
| 0907240 | LEU & LYM 22 MARKERS | $ - 0 | |||
| 0907244 | LEU & LYM 26 MARKERS | $ - 0 | |||
| 0900182 | PLAT AGG W/RIST-MVH | $ - 0 | |||
| 0951036 | TACROLIMUS | $ - 0 | |||
| 0975865 | ADD'L IMMUNOSTAIN X 2 | $ - 0 | |||
| 0907165 | BLOOD SMEAR | $ - 0 | |||
| 0903601 | BONE MARROW SMEAR | $ - 0 | |||
| 0907167 | DECALCIFICATION | $ - 0 | |||
| 0950584 | FISH (QUALITATIVE) X 1 | $ - 0 | |||
| 0905454 | IMMUNOPEROXIDASE | $ - 0 | |||
| 0907241 | LEU & LYM 23 MARKERS | $ - 0 | |||
| 0905871 | LEVEL IV - 2 SPECS | $ - 0 | |||
| 0975897 | ADD'L FISH QUAL X 1 | $ - 0 | |||
| 0975873 | ADD'L IMMUNOSTAIN X 10 | $ - 0 | |||
| 0950473 | FACTOR V INHIBITOR | $ - 0 | |||
| 0907131 | FACTOR XA | $ - 0 | |||
| 0907231 | LEU & LYM 13 MARKERS | $ - 0 | |||
| 0907242 | LEU & LYM 24 MARKERS | $ - 0 | |||
| 0907243 | LEU & LYM 25 MARKERS | $ - 0 | |||
| 0906524 | MICROORG STAIN X 3 | $ - 0 | |||
| 0906529 | NONMICROORG STAINS 3 | $ - 0 | |||
| 0951488 | S2 CYTOCHEMICAL STAIN | $ - 0 | |||
| 2012710 | Aggressive B-Cell Lymphoma Rflx, Tissue | $ - 0 | |||
| 2006102 | ALK by FISH, Lung | $ - 0 | |||
| 0093271 | Bone Marrow/PBL Culture Bill | $ - 0 | |||
| 2002440 | EGFR by Pyrosequencing | $ - 0 | |||
| 0090299 | Epithelial Skin Antibodies | $ - 0 | |||
| 0050591 | Ganglioside (GM1) Antibodies, IgG/IgM | $ - 0 | |||
| 2004998 | Ganglioside (GM1/GD1b/GQ1b) Abs, IgG/IgM | $ - 0 | |||
| 0051033 | Ganglioside Antibodies, Combined IgG/IgM | $ - 0 | |||
| 2010757 | Hereditary Cancer Pan, Del/Dup | $ - 0 | |||
| 0051367 | Hypochondroplasia (FGFR3) 2 Mutations | $ - 0 | |||
| 0055557 | IGH-CCND1 (BCL-1/JH) t(11;14) PCR | $ - 0 | |||
| 2000770 | IHC BillG Nerve Fiber PGP9.5 | $ - 0 | |||
| 0070413 | Inhibin B | $ - 0 | |||
| 0096043 | Lymphocyte Mitogen Proliferation | $ - 0 | |||
| 2002499 | MLH1 Methylation by PCR | $ - 0 | |||
| 2002360 | MPD Panel by FISH | $ - 0 | |||
| 2009318 | MYD88 L265P Mutation Detection by PCR | $ - 0 | |||
| 2011117 | Myeloid Malignancies Mutation Panel NGS | $ - 0 | |||
| 2004221 | N-methyl-D-Aspartate Rcptr Ab, IgG, Ser | $ - 0 | |||
| 2005164 | N-methyl-D-Aspartate Receptor Ab, CSF | $ - 0 | |||
| 2013008 | PJI Detection (Synovasure) | $ - 0 | |||
| 2012018 | Skeletal Dysplasia Sequencing | $ - 0 | |||
| 2007991 | Solid Tumor Mutation Panel by NGS | $ - 0 | |||
| 0051139 | Specimen Identity | $ - 0 |
File details come from the government source that posted it. Updated .